IP Library Granted Patent US 12667607
Granted Patent B2
US 12667607 · App. 18/315,351 · Granted Jun 30, 2026

Methods of reducing collagenase-mediated bruising in a subject having cellulite

Inventors: Saji Vijayan (Downingtown, PA); David Hernandez (Lititz, PA); James Patrick Tursi (Moorestown, NJ)
Assignee: Endo Operations Limited
A61K38/4886A61K9/0019A61P17/02A61P19/04C12Y304/24007
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12667607
App. No.
18/315,351
Granted
Jun 30, 2026
Kind
B2
Abstract

Disclosed herein are methods of reducing collagenase-mediated bruising in a subject having cellulite, methods of treating cellulite in a subject, and collagenase-containing formulations.

Claims (12)

1 . A method of reducing bruising and/or skin discoloration associated with collagenase-mediated treatment of cellulite in a subject, the method comprising:

subcutaneously administering to a treatment area of the subject a total dose of about 0.42 mg of collagenase per treatment session to thereby reduce the bruising and/or skin discoloration associated with the collagenase-mediated treatment of cellulite in the subject, wherein the subject experiences an at least 1 level improvement on an Investigator Assessment of Bruising Severity Scale (IABSS).

2 . The method of claim 1 , wherein the collagenase is administered using a three-injection technique.

3 . The method of claim 2 , wherein the collagenase is administered at a depth of about 0.5 inches.

4 . The method of claim 1 , wherein the collagenase has a concentration of about 0.23 mg/ml.

5 . The method of claim 1 , wherein the subject receives multiple treatment sessions.

6 . The method of claim 5 , wherein the treatment sessions are 3 weeks apart.

7 . The method of claim 1 , wherein the collagenase is administered in a composition comprising the collagenase, mannitol, sucrose, and tromethamine.

8 . The method of claim 1 , wherein the collagenase comprises a collagenase I, a collagenase II, or a mixture of collagenase I and collagenase II.

9 . The method of claim 8 , wherein the collagenase comprises the mixture of collagenase I and collagenase II.

10 . The method of claim 9 , wherein the collagenase I comprises the amino acid sequence of SEQ ID NO: 1 and the collagenase II comprises the amino acid sequence of SEQ ID NO: 2.

11 . The method of claim 8 , wherein the collagenase is collagenase Clostridium histolyticum (CCH).